(CRSP) Crispr Therapeutics Weekly charts technical analysis
(CRSP) Crispr Therapeutics Weekly charts technical analysis Weekly analysis of Crispr Therapeutics | Buy/Sell Crispr Therapeutics
Crispr Therapeutics trades in USA in Health Care sector.
10 day averaged volume of Crispr Therapeutics is 1948230
Date | Closing Price | Open | High | Low | Volume |
26 Tue Nov 2024 | 49.31 | 50.00 | 50.63 | 48.49 | 1.19 Mn |
26 Tue Nov 2024 | 49.31 | 49.21 | 51.73 | 48.49 | 3.414 Mn |
22 Fri Nov 2024 | 47.88 | 47.83 | 48.28 | 45.51 | 9.115 Mn |
15 Fri Nov 2024 | 47.25 | 53.13 | 59.07 | 46.30 | 12.788 Mn |
08 Fri Nov 2024 | 51.62 | 50.44 | 53.26 | 47.04 | 8.956 Mn |
01 Fri Nov 2024 | 50.76 | 47.99 | 50.85 | 46.30 | 7.6 Mn |
25 Fri Oct 2024 | 47.36 | 48.59 | 48.94 | 45.44 | 5.664 Mn |
18 Fri Oct 2024 | 48.92 | 46.74 | 49.28 | 46.10 | 4.852 Mn |
11 Fri Oct 2024 | 46.85 | 45.43 | 47.50 | 44.44 | 4.216 Mn |
04 Fri Oct 2024 | 45.37 | 46.94 | 47.69 | 44.61 | 5.452 Mn |
Indicators analysis of Crispr Therapeutics (CRSP)
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Crispr Therapeutics stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Crispr Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Crispr Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Crispr Therapeutics in short term but SELL signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Crispr Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 48.48 and Crispr Therapeutics (CRSP) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Crispr Therapeutics (CRSP) stock. Volume based technical analysis of Crispr Therapeutics (CRSP) stock is negative.
Crispr Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Weekly charts
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Crispr Therapeutics stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Crispr Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Crispr Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Crispr Therapeutics in short term but SELL signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Crispr Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 48.48 and Crispr Therapeutics (CRSP) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Crispr Therapeutics (CRSP) stock. Volume based technical analysis of Crispr Therapeutics (CRSP) stock is negative.
Crispr Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.